Elevate your local knowledge
Sign up for the iNFOnews newsletter today!

VANCOUVER – Canadian biotechnology company QLT Inc. is cutting its workforce by two-thirds, leaving it with 68 employees after the downsizing.
The Vancouver-based company (TSX:QLT) had been one of Canada’s most successful biotechnology firms based on its treatment for age-related blindness.
But sales of Visudyne have fallen and QLT has struggled in recent years to find another commercially successful product.
As a result, QLT’s chairman says the company is cutting 146 of its 214 remaining jobs.
He says the downsizing will reduce QLT’s annual operating expenses by $45 million to $50 million in 2013.
QLT’s new board of directors has also authorized a payout of $100 million to its shareholders in a process known as a return of capital.
News from © iNFOnews.ca, . All rights reserved.
This material may not be published, broadcast, rewritten or redistributed.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Want to share your thoughts, add context, or connect with others in your community?
You must be logged in to post a comment.